{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:57:56Z","timestamp":1793127476974,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013348","name":"Innosuisse - Schweizerische Agentur f\u00fcr Innovationsf\u00f6rderung","doi-asserted-by":"publisher","award":["35449.1 IP-LS"],"award-info":[{"award-number":["35449.1 IP-LS"]}],"id":[{"id":"10.13039\/501100013348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013348","name":"Innosuisse - Schweizerische Agentur f\u00fcr Innovationsf\u00f6rderung","doi-asserted-by":"publisher","award":["35449.1 IP-LS"],"award-info":[{"award-number":["35449.1 IP-LS"]}],"id":[{"id":"10.13039\/501100013348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013348","name":"Innosuisse - Schweizerische Agentur f\u00fcr Innovationsf\u00f6rderung","doi-asserted-by":"publisher","award":["35449.1 IP-LS"],"award-info":[{"award-number":["35449.1 IP-LS"]}],"id":[{"id":"10.13039\/501100013348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013348","name":"Innosuisse - Schweizerische Agentur f\u00fcr Innovationsf\u00f6rderung","doi-asserted-by":"publisher","award":["35449.1 IP-LS"],"award-info":[{"award-number":["35449.1 IP-LS"]}],"id":[{"id":"10.13039\/501100013348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013348","name":"Innosuisse - Schweizerische Agentur f\u00fcr Innovationsf\u00f6rderung","doi-asserted-by":"publisher","award":["35449.1 IP-LS"],"award-info":[{"award-number":["35449.1 IP-LS"]}],"id":[{"id":"10.13039\/501100013348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013348","name":"Innosuisse - Schweizerische Agentur f\u00fcr Innovationsf\u00f6rderung","doi-asserted-by":"publisher","award":["35449.1 IP-LS"],"award-info":[{"award-number":["35449.1 IP-LS"]}],"id":[{"id":"10.13039\/501100013348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018460","name":"Gelu Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018460","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_214903  and 320030-227541"],"award-info":[{"award-number":["310030_214903  and 320030-227541"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_214903  and 320030-227541"],"award-info":[{"award-number":["310030_214903  and 320030-227541"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mecri Foundation"},{"name":"The Charitable Gabriele Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    A slow decline in the autophagy-lysosomal pathway is a hallmark of the normal aging brain. Yet, an acceleration of this cellular function may propel neurodegenerative events. In fact, mutations in genes associated with the autophagy-lysosomal pathway can lead to Parkinson\u2019s disease. Also, amyloidogenic protein deposition is observed in lysosomal storage disorders, which are caused by genetic mutations representing risk factors for Parkinson\u2019s disease. For example, Gaucher\u2019s disease\n                    <jats:italic>GBA1<\/jats:italic>\n                    mutations leading to defects in lysosomal sphingolipid metabolism cause \u03b1-synuclein accumulation. We observed that increased lysosomal Tau accumulation is found in human dermal fibroblasts engineered for inducible Tau expression. Inhibition of the\n                    <jats:italic>GBA1<\/jats:italic>\n                    product GCase augmented Tau-dependent lysosomal stress and Tau accumulation. Here, we show increased Tau seed-induced Tau accumulation in Gaucher\u2019s fibroblasts carrying\n                    <jats:italic>GBA1<\/jats:italic>\n                    mutations when compared to normal fibroblasts. Pharmacological enhancement of GCase reversed this effect, notably, also in normal fibroblasts. This suggests that boosting GCase activity may represent a therapeutic strategy to slow down aging-dependent lysosomal deficits and brain protein deposition.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-02346-8","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T05:48:43Z","timestamp":1747806523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A novel allosteric GCase modulator prevents Tau accumulation in GBA1WT and GBA1L444P\/L444P cellular models"],"prefix":"10.1038","volume":"15","author":[{"given":"Matteo","family":"Ciccaldo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e0lia","family":"P\u00e9rez-Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Piovesana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Cano-Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ruano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Fregno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Calvo-Flores Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manolo","family":"Bellotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Molinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Papin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Garc\u00eda-Collazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Paganetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"2346_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","volume":"86","author":"F Chiti","year":"2017","unstructured":"Chiti, F., Dobson, C. M. & Protein Misfolding Amyloid formation, and human disease: A summary of progress over the last decade. Annu. Rev. Biochem. 86, 27\u201368 (2017).","journal-title":"Annu. Rev. Biochem."},{"key":"2346_CR2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.1132814","volume":"314","author":"M Goedert","year":"2006","unstructured":"Goedert, M. & Spillantini, M. G. A century of Alzheimer\u2019s disease. Science 314, 777\u2013781 (2006).","journal-title":"Science"},{"key":"2346_CR3","doi-asserted-by":"publisher","first-page":"S517","DOI":"10.3233\/JAD-179907","volume":"64","author":"RM Nisbet","year":"2018","unstructured":"Nisbet, R. M. & G\u00f6tz, J. Amyloid-\u03b2 and Tau in Alzheimer\u2019s disease: novel pathomechanisms and Non-Pharmacological treatment strategies. J. Alzheimers Dis. JAD. 64, S517\u2013S527 (2018).","journal-title":"J. Alzheimers Dis. JAD"},{"key":"2346_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00441-017-2706-9","volume":"373","author":"MG Spillantini","year":"2018","unstructured":"Spillantini, M. G. & Goedert, M. Neurodegeneration and the ordered assembly of \u03b1-synuclein. Cell. Tissue Res. 373, 137\u2013148 (2018).","journal-title":"Cell. Tissue Res."},{"key":"2346_CR5","doi-asserted-by":"publisher","first-page":"602116","DOI":"10.3389\/fncel.2020.602116","volume":"14","author":"S Gioved\u00ec","year":"2020","unstructured":"Gioved\u00ec, S., Ravanelli, M. M., Parisi, B., Bettegazzi, B. & Guarnieri, F. C. Dysfunctional autophagy and endolysosomal system in neurodegenerative diseases: relevance and therapeutic options. Front. Cell. Neurosci. 14, 602116 (2020).","journal-title":"Front. Cell. Neurosci."},{"key":"2346_CR6","doi-asserted-by":"publisher","first-page":"a033993","DOI":"10.1101\/cshperspect.a033993","volume":"12","author":"S Finkbeiner","year":"2020","unstructured":"Finkbeiner, S. The autophagy lysosomal pathway and neurodegeneration. Cold Spring Harb Perspect. Biol. 12, a033993 (2020).","journal-title":"Cold Spring Harb Perspect. Biol."},{"key":"2346_CR7","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nm.3232","volume":"19","author":"RA Nixon","year":"2013","unstructured":"Nixon, R. A. The role of autophagy in neurodegenerative disease. Nat. Med. 19, 983\u2013997 (2013).","journal-title":"Nat. Med."},{"key":"2346_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1146\/annurev-neuro-070815-014031","volume":"39","author":"A Fraldi","year":"2016","unstructured":"Fraldi, A., Klein, A. D., Medina, D. L. & Settembre, C. Brain disorders due to lysosomal dysfunction. Annu. Rev. Neurosci. 39, 277\u2013295 (2016).","journal-title":"Annu. Rev. Neurosci."},{"key":"2346_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fnmol.2020.00037","volume":"13","author":"A Monaco","year":"2020","unstructured":"Monaco, A. & Fraldi, A. Protein aggregation and dysfunction of Autophagy-Lysosomal pathway: A vicious cycle in lysosomal storage diseases. Front. Mol. Neurosci. 13, 37 (2020).","journal-title":"Front. Mol. Neurosci."},{"key":"2346_CR10","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/mds.23774","volume":"26","author":"T Shachar","year":"2011","unstructured":"Shachar, T. et al. Lysosomal storage disorders and Parkinson\u2019s disease: gaucher disease and beyond. Mov. Disord Off J. Mov. Disord Soc. 26, 1593\u20131604 (2011).","journal-title":"Mov. Disord Off J. Mov. Disord Soc."},{"key":"2346_CR11","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1093\/brain\/awx285","volume":"140","author":"LA Robak","year":"2017","unstructured":"Robak, L. A. et al. Excessive burden of lysosomal storage disorder gene variants in Parkinson\u2019s disease. Brain J. Neurol. 140, 3191\u20133203 (2017).","journal-title":"Brain J. Neurol."},{"key":"2346_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40035-020-00226-x","volume":"10","author":"T Behl","year":"2021","unstructured":"Behl, T. et al. Cross-talks among GBA mutations, glucocerebrosidase, and \u03b1-synuclein in GBA-associated Parkinson\u2019s disease and their targeted therapeutic approaches: a comprehensive review. Transl Neurodegener. 10, 4 (2021).","journal-title":"Transl Neurodegener"},{"key":"2346_CR13","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1093\/brain\/awu020","volume":"137","author":"A McNeill","year":"2014","unstructured":"McNeill, A. et al. Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells. Brain J. Neurol. 137, 1481\u20131495 (2014).","journal-title":"Brain J. Neurol."},{"key":"2346_CR14","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/ana.23614","volume":"72","author":"ME Gegg","year":"2012","unstructured":"Gegg, M. E. et al. Glucocerebrosidase deficiency in substantia Nigra of Parkinson disease brains. Ann. Neurol. 72, 455\u2013463 (2012).","journal-title":"Ann. Neurol."},{"key":"2346_CR15","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.3390\/ijms24054437","volume":"24","author":"EV Grigor\u2019eva","year":"2023","unstructured":"Grigor\u2019eva, E. V. et al. Biochemical characteristics of iPSC-Derived dopaminergic neurons from N370S GBA variant carriers with and without Parkinson\u2019s disease. Int. J. Mol. Sci. 24, 4437 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2346_CR16","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/mds.28688","volume":"36","author":"A Emelyanov","year":"2021","unstructured":"Emelyanov, A. et al. Increased \u03b1-Synuclein level in CD45\u2009+\u2009Blood cells in asymptomatic carriers of GBA mutations. Mov. Disord Off J. Mov. Disord Soc. 36, 1997\u20131998 (2021).","journal-title":"Mov. Disord Off J. Mov. Disord Soc."},{"key":"2346_CR17","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/mds.29132","volume":"37","author":"AE Kopytova","year":"2022","unstructured":"Kopytova, A. E. et al. Could blood hexosylsphingosine be a marker for Parkinson\u2019s disease linked with GBA1 mutations?? Mov. Disord Off J. Mov. Disord Soc. 37, 1779\u20131781 (2022).","journal-title":"Mov. Disord Off J. Mov. Disord Soc."},{"key":"2346_CR18","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/brain\/awt367","volume":"137","author":"KE Murphy","year":"2014","unstructured":"Murphy, K. E. et al. Reduced glucocerebrosidase is associated with increased \u03b1-synuclein in sporadic Parkinson\u2019s disease. Brain J. Neurol. 137, 834\u2013848 (2014).","journal-title":"Brain J. Neurol."},{"key":"2346_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13041-020-00712-3","volume":"14","author":"R Thomas","year":"2021","unstructured":"Thomas, R., Moloney, E. B., Macbain, Z. K., Hallett, P. J. & Isacson, O. Fibroblasts from idiopathic Parkinson\u2019s disease exhibit deficiency of lysosomal glucocerebrosidase activity associated with reduced levels of the trafficking receptor LIMP2. Mol. Brain. 14, 16 (2021).","journal-title":"Mol. Brain"},{"key":"2346_CR20","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1080\/15548627.2015.1086055","volume":"11","author":"TT Du","year":"2015","unstructured":"Du, T. T. et al. GBA deficiency promotes SNCA\/\u03b1-synuclein accumulation through autophagic Inhibition by inactivated PPP2A. Autophagy 11, 1803\u20131820 (2015).","journal-title":"Autophagy"},{"key":"2346_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","volume":"146","author":"JR Mazzulli","year":"2011","unstructured":"Mazzulli, J. R. et al. Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146, 37\u201352 (2011).","journal-title":"Cell"},{"key":"2346_CR22","doi-asserted-by":"publisher","first-page":"28080","DOI":"10.1074\/jbc.M111.237859","volume":"286","author":"TL Yap","year":"2011","unstructured":"Yap, T. L. et al. Alpha-synuclein interacts with glucocerebrosidase providing a molecular link between Parkinson and gaucher diseases. J. Biol. Chem. 286, 28080\u201328088 (2011).","journal-title":"J. Biol. Chem."},{"key":"2346_CR23","doi-asserted-by":"publisher","first-page":"106534","DOI":"10.1016\/j.bpc.2020.106534","volume":"273","author":"SS Mu\u00f1oz","year":"2021","unstructured":"Mu\u00f1oz, S. S., Petersen, D., Marlet, F. R., K\u00fcc\u00fckk\u00f6se, E. & Galvagnion, C. The interplay between glucocerebrosidase, \u03b1-synuclein and lipids in human models of Parkinson\u2019s disease. Biophys. Chem. 273, 106534 (2021).","journal-title":"Biophys. Chem."},{"key":"2346_CR24","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1111\/febs.14393","volume":"285","author":"ME Gegg","year":"2018","unstructured":"Gegg, M. E. & Schapira, A. H. V. The role of glucocerebrosidase in Parkinson disease pathogenesis. FEBS J. 285, 3591\u20133603 (2018).","journal-title":"FEBS J."},{"key":"2346_CR25","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1093\/brain\/awae070","volume":"147","author":"JC Rubilar","year":"2024","unstructured":"Rubilar, J. C., Outeiro, T. F. & Klein, A. D. The lysosomal \u03b2-glucocerebrosidase strikes mitochondria: implications for Parkinson\u2019s therapeutics. Brain J. Neurol. 147, 2610\u20132620 (2024).","journal-title":"Brain J. Neurol."},{"key":"2346_CR26","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1038\/s41467-023-37454-4","volume":"14","author":"P Baden","year":"2023","unstructured":"Baden, P. et al. Glucocerebrosidase is imported into mitochondria and preserves complex I integrity and energy metabolism. Nat. Commun. 14, 1930 (2023).","journal-title":"Nat. Commun."},{"key":"2346_CR27","doi-asserted-by":"crossref","unstructured":"Kuppuramalingam, A., Cabasso, O. & Horowitz, M. Functional Analysis of Human GBA1 Missense Mutations in Drosophila: Insights into Gaucher Disease Pathogenesis and Phenotypic Consequences. Cells 13, 1619 (2024).","DOI":"10.3390\/cells13191619"},{"key":"2346_CR28","doi-asserted-by":"publisher","first-page":"18024","DOI":"10.1038\/s41598-023-44979-7","volume":"13","author":"E Piovesana","year":"2023","unstructured":"Piovesana, E. et al. Tau accumulation in degradative organelles is associated to lysosomal stress. Sci. Rep. 13, 18024 (2023).","journal-title":"Sci. Rep."},{"key":"2346_CR29","unstructured":"Alonso, X. B., Garcia, D. A. & Schmidtke, P. Method of binding site and binding energy determination by mixed explicit solvent simulations. Patent WO2013092922A2 (2013)."},{"key":"2346_CR30","unstructured":"Collazo, A. M. G., Jorda, E. C., Bellotto, M. & Iglesias, E. F. Heteroaryl compounds and therapeutic uses thereof in conditions associated with the alteration of the activity of beta-glucocerebrosidase. Patent WO2021105908A1 (2021)."},{"key":"2346_CR31","doi-asserted-by":"publisher","first-page":"8530","DOI":"10.1021\/jm5010418","volume":"57","author":"D Alvarez-Garcia","year":"2014","unstructured":"Alvarez-Garcia, D. & Barril, X. Molecular simulations with solvent competition quantify water displaceability and provide accurate interaction maps of protein binding sites. J. Med. Chem. 57, 8530\u20138539 (2014).","journal-title":"J. Med. Chem."},{"key":"2346_CR32","doi-asserted-by":"publisher","first-page":"e231221199369","DOI":"10.2174\/1570163819666211223162829","volume":"19","author":"D Alvarez-Garcia","year":"2022","unstructured":"Alvarez-Garcia, D., Schmidtke, P., Cubero, E. & Barril, X. Extracting atomic contributions to binding free energy using moleculardynamics simulations with mixed solvents (MDmix). Curr. Drug Discov Technol. 19, e231221199369 (2022).","journal-title":"Curr. Drug Discov Technol."},{"key":"2346_CR33","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1467-7652.2007.00263.x","volume":"5","author":"Y Shaaltiel","year":"2007","unstructured":"Shaaltiel, Y. et al. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher\u2019s disease using a plant cell system. Plant. Biotechnol. J. 5, 579\u2013590 (2007).","journal-title":"Plant. Biotechnol. J."},{"key":"2346_CR34","doi-asserted-by":"publisher","first-page":"e1003571","DOI":"10.1371\/journal.pcbi.1003571","volume":"10","author":"S Ruiz-Carmona","year":"2014","unstructured":"Ruiz-Carmona, S. et al. rDock: a fast, versatile and open source program for Docking ligands to proteins and nucleic acids. PLoS Comput. Biol. 10, e1003571 (2014).","journal-title":"PLoS Comput. Biol."},{"key":"2346_CR35","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev.biophys.26.1.541","volume":"26","author":"P Schuck","year":"1997","unstructured":"Schuck, P. Use of surface plasmon resonance to probe the equilibrium and dynamic aspects of interactions between biological macromolecules. Annu. Rev. Biophys. Biomol. Struct. 26, 541\u2013566 (1997).","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"2346_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bbamem.2013.04.028","volume":"1838","author":"SG Patching","year":"2014","unstructured":"Patching, S. G. Surface plasmon resonance spectroscopy for characterisation of membrane protein-ligand interactions and its potential for drug discovery. Biochim. Biophys. Acta. 1838, 43\u201355 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"2346_CR37","doi-asserted-by":"publisher","first-page":"23815","DOI":"10.1074\/jbc.M502799200","volume":"280","author":"L Premkumar","year":"2005","unstructured":"Premkumar, L. et al. X-ray structure of human acid-beta-glucosidase covalently bound to conduritol-B-epoxide. Implications for gaucher disease. J. Biol. Chem. 280, 23815\u201323819 (2005).","journal-title":"J. Biol. Chem."},{"key":"2346_CR38","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1089\/ars.2015.6307","volume":"23","author":"EM Rocha","year":"2015","unstructured":"Rocha, E. M. et al. Sustained systemic glucocerebrosidase Inhibition induces brain \u03b1-Synuclein aggregation, microglia and complement C1q activation in mice. Antioxid. Redox Signal. 23, 550\u2013564 (2015).","journal-title":"Antioxid. Redox Signal."},{"key":"2346_CR39","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1089\/dna.2021.0485","volume":"40","author":"G Pedrioli","year":"2021","unstructured":"Pedrioli, G. et al. Tau seeds in extracellular vesicles induce Tau accumulation in degradative organelles of cells. DNA Cell. Biol. 40, 1185\u20131199 (2021).","journal-title":"DNA Cell. Biol."},{"key":"2346_CR40","doi-asserted-by":"publisher","first-page":"43223","DOI":"10.1074\/jbc.M112.396176","volume":"287","author":"K Flach","year":"2012","unstructured":"Flach, K. et al. Tau oligomers impair artificial membrane integrity and cellular viability. J. Biol. Chem. 287, 43223\u201343233 (2012).","journal-title":"J. Biol. Chem."},{"key":"2346_CR41","doi-asserted-by":"publisher","first-page":"14234","DOI":"10.1523\/JNEUROSCI.1523-15.2015","volume":"35","author":"M Usenovic","year":"2015","unstructured":"Usenovic, M. et al. Internalized Tau oligomers cause neurodegeneration by inducing accumulation of pathogenic Tau in human neurons derived from induced pluripotent stem cells. J. Neurosci. Off J. Soc. Neurosci. 35, 14234\u201314250 (2015).","journal-title":"J. Neurosci. Off J. Soc. Neurosci."},{"key":"2346_CR42","doi-asserted-by":"publisher","first-page":"e907","DOI":"10.1038\/tp.2016.186","volume":"6","author":"SS Jiao","year":"2016","unstructured":"Jiao, S. S. et al. Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer\u2019s disease. Transl Psychiatry. 6, e907 (2016).","journal-title":"Transl Psychiatry"},{"key":"2346_CR43","first-page":"62","volume":"19","author":"D Alvarez-Garcia","year":"2022","unstructured":"Alvarez-Garcia, D., Schmidtke, P., Cubero, E. & Barril, X. Extracting atomic contributions to binding free energy using molecular dynamics simulations with mixed solvents (MDmix). Curr. Drug Discov Technol. 19, 62\u201368 (2022).","journal-title":"Curr. Drug Discov Technol."},{"key":"2346_CR44","doi-asserted-by":"publisher","first-page":"e0294437","DOI":"10.1371\/journal.pone.0294437","volume":"18","author":"M Rudinskiy","year":"2023","unstructured":"Rudinskiy, M. et al. Validation of a highly sensitive HaloTag-based assay to evaluate the potency of a novel class of allosteric \u03b2-Galactosidase correctors. PloS One. 18, e0294437 (2023).","journal-title":"PloS One"},{"key":"2346_CR45","doi-asserted-by":"publisher","first-page":"e0303789","DOI":"10.1371\/journal.pone.0303789","volume":"19","author":"E Cubero","year":"2024","unstructured":"Cubero, E. et al. Discovery of allosteric regulators with clinical potential to stabilize alpha-L-iduronidase in mucopolysaccharidosis type I. PloS One. 19, e0303789 (2024).","journal-title":"PloS One"},{"key":"2346_CR46","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ymgme.2015.12.002","volume":"117","author":"J Condori","year":"2016","unstructured":"Condori, J. et al. Enzyme replacement for GM1-gangliosidosis: uptake, lysosomal activation, and cellular disease correction using a novel \u03b2-galactosidase:RTB lectin fusion. Mol. Genet. Metab. 117, 199\u2013209 (2016).","journal-title":"Mol. Genet. Metab."},{"key":"2346_CR47","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1523\/JNEUROSCI.0680-22.2022","volume":"43","author":"CL Mahoney-Crane","year":"2023","unstructured":"Mahoney-Crane, C. L. et al. Neuronopathic GBA1L444P mutation accelerates glucosylsphingosine levels and formation of hippocampal Alpha-Synuclein inclusions. J. Neurosci. Off J. Soc. Neurosci. 43, 501\u2013521 (2023).","journal-title":"J. Neurosci. Off J. Soc. Neurosci."},{"key":"2346_CR48","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nature04723","volume":"441","author":"M Komatsu","year":"2006","unstructured":"Komatsu, M. et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441, 880\u2013884 (2006).","journal-title":"Nature"},{"key":"2346_CR49","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nature04724","volume":"441","author":"T Hara","year":"2006","unstructured":"Hara, T. et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441, 885\u2013889 (2006).","journal-title":"Nature"},{"key":"2346_CR50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.nbd.2010.08.015","volume":"43","author":"A Yamamoto","year":"2011","unstructured":"Yamamoto, A. & Simonsen, A. The elimination of accumulated and aggregated proteins: a role for aggrephagy in neurodegeneration. Neurobiol. Dis. 43, 17\u201328 (2011).","journal-title":"Neurobiol. Dis."},{"key":"2346_CR51","doi-asserted-by":"crossref","unstructured":"Sardi, S. P. et al. Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies. Proc. Natl. Acad. Sci. U. S. A. 110, 3537\u20133542 (2013).","DOI":"10.1073\/pnas.1220464110"},{"key":"2346_CR52","doi-asserted-by":"publisher","first-page":"548","DOI":"10.4161\/auto.5.4.8364","volume":"5","author":"CD Pacheco","year":"2009","unstructured":"Pacheco, C. D., Elrick, M. J. & Lieberman, A. P. Tau normal function influences Niemann-Pick type C disease pathogenesis in mice and modulates autophagy in NPC1-deficient cells. Autophagy 5, 548\u2013550 (2009).","journal-title":"Autophagy"},{"key":"2346_CR53","doi-asserted-by":"publisher","first-page":"8332","DOI":"10.1073\/pnas.0903223106","volume":"106","author":"K Ohmi","year":"2009","unstructured":"Ohmi, K. et al. Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathy. Proc. Natl. Acad. Sci. U S A. 106, 8332\u20138337 (2009).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"2346_CR54","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3390\/biomedicines9050446","volume":"9","author":"J Clarke","year":"2021","unstructured":"Clarke, J., Kayatekin, C., Viel, C., Shihabuddin, L. & Sardi, S. P. Murine models of lysosomal storage diseases exhibit differences in brain protein aggregation and neuroinflammation. Biomedicines 9, 446 (2021).","journal-title":"Biomedicines"},{"key":"2346_CR55","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1093\/hmg\/ddac038","volume":"31","author":"SY Yang","year":"2022","unstructured":"Yang, S. Y., Taanman, J. W., Gegg, M. & Schapira, A. H. V. Ambroxol reverses Tau and \u03b1-synuclein accumulation in a cholinergic N370S GBA1 mutation model. Hum. Mol. Genet. 31, 2396\u20132405 (2022).","journal-title":"Hum. Mol. Genet."},{"key":"2346_CR56","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.1038\/ncomms5755","volume":"5","author":"EJ Bae","year":"2014","unstructured":"Bae, E. J. et al. Glucocerebrosidase depletion enhances cell-to-cell transmission of \u03b1-synuclein. Nat. Commun. 5, 4755 (2014).","journal-title":"Nat. Commun."},{"key":"2346_CR57","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1212\/WNL.0b013e3182735e9a","volume":"79","author":"D Tsuang","year":"2012","unstructured":"Tsuang, D. et al. GBA mutations increase risk for lewy body disease with and without alzheimer disease pathology. Neurology 79, 1944\u20131950 (2012).","journal-title":"Neurology"},{"key":"2346_CR58","doi-asserted-by":"publisher","first-page":"682","DOI":"10.4103\/1673-5374.321000","volume":"17","author":"YF Wen","year":"2022","unstructured":"Wen, Y. F. et al. Mutations in GBA, SNCA, and VPS35 are not associated with Alzheimer\u2019s disease in a Chinese population: a case-control study. Neural Regen Res. 17, 682\u2013689 (2022).","journal-title":"Neural Regen Res."},{"key":"2346_CR59","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41531-024-00728-9","volume":"10","author":"IL Dellarole","year":"2024","unstructured":"Dellarole, I. L. et al. Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies. NPJ Park Dis. 10, 116 (2024).","journal-title":"NPJ Park Dis."},{"key":"2346_CR60","doi-asserted-by":"publisher","first-page":"7516","DOI":"10.1523\/JNEUROSCI.4182-09.2010","volume":"30","author":"P Garcia","year":"2010","unstructured":"Garcia, P. et al. Ciliary neurotrophic factor cell-based delivery prevents synaptic impairment and improves memory in mouse models of Alzheimer\u2019s disease. J. Neurosci. Off J. Soc. Neurosci. 30, 7516\u20137527 (2010).","journal-title":"J. Neurosci. Off J. Soc. Neurosci."},{"key":"2346_CR61","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.foodchem.2014.09.028","volume":"171","author":"MH Roby","year":"2015","unstructured":"Roby, M. H. et al. Enzymatic production of bioactive docosahexaenoic acid phenolic ester. Food Chem. 171, 397\u2013404 (2015).","journal-title":"Food Chem."},{"key":"2346_CR62","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-151110","volume":"52","author":"J Colin","year":"2016","unstructured":"Colin, J. et al. Improved neuroprotection provided by drug combination in neurons exposed to Cell-Derived soluble Amyloid-\u03b2 peptide. J. Alzheimers Dis. JAD. 52, 975\u2013987 (2016).","journal-title":"J. Alzheimers Dis. JAD"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02346-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02346-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02346-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T07:02:48Z","timestamp":1747810968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02346-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2346"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-02346-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.08.13.607706","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"26 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17646"}}